Understanding injectable versus oral peptide differences helps inform this decision
Semaglutide and tirzepatide commonly cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort
While semaglutide targets the GLP-1 receptor, tirzepatide acts as a dual agonist (GLP-1 and GIP), which may influence the profile of adverse events
GHK-Cu (Copper Peptide) - Common Uses: Anti-aging, wound healing, skin repair
Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice
*IMPORTANT DISCLAIMER: All products sold are strictly for research purposes only.Please review our Terms and Conditions and the FAQ section of this website to fully understand the implications of the use of our research products.